GlaxoSmithKline plc RSS feed
http://www.thisislondon.co.uk/standard/related-36915-glaxosmithkline-plc/topic-rss.do
GlaxoSmithKline plc RSS feedGlaxo £300m deal on nicotine vaccine
http://www.thisislondon.co.uk/standard-business/article-23770179-glaxo-pound-300m-deal-on-nicotine-vaccine.do
Smokers could receive a vaccine to help kick the nicotine habit if GlaxoSmithKline’s latest $500 million (£300 million) deal works out2009-11-16T13:05:03ZMetals add lustre to miners as dollar is in the doldrums
http://www.thisislondon.co.uk/standard-business/article-23766680-metals-add-lustre-to-miners-as-dollar-is-in-the-doldrums.do
The price of gold traded at a record high of $1108.00 an ounce on world markets today in response to a weaker dollar2009-11-09T13:31:29ZGlaxo cashes in on swine flu jab rush
http://www.thisislondon.co.uk/standard-business/article-23761884-glaxo-cashes-in-on-swine-flu-jab-rush.do
GlaxoSmithKline, the drug company producing the bulk of Britain’s swine flu vaccine, said third-quarter pre-tax profit soared 23% to £1.91 billion as the firm cashed in from a boost in emerging markets and H1N1 drugs2009-10-28T13:22:44ZGlaxo lifted after US approves drug
http://www.thisislondon.co.uk/standard-business/article-23761085-glaxo-lifted-after-us-approves-drug.do
GlaxoSmithKline today received a boost after the Food and Drug Administration in the US approved its leukaemia medicine Arzerra2009-10-27T08:30:30ZGlaxo’s £11m for new science park
http://www.thisislondon.co.uk/standard-business/article-23755880-glaxos-pound-11m-for-new-science-park.do
GlaxoSmithKline announced it is spending £11 million creating a science park in Stevenage that will house 1500 biotech experts2009-10-13T11:34:51ZGlaxo starts to shift swine flu vaccine worth £2.2bn
http://www.thisislondon.co.uk/standard-business/article-23752854-glaxo-starts-to-shift-swine-flu-vaccine-worth-pound-22bn.do
GlaxoSmithKline announced it had started to dispatch its swine flu vaccine around the world and said it has received contracts for 440 million doses of its pandemic vaccine2009-10-06T07:04:24ZSwine flu’s £1.8bn boost for Glaxo
http://www.thisislondon.co.uk/standard-business/article-23728200-swine-flus-18bn-boost-for-glaxo.do
GlaxoSmithKline is set to cash in on £1.8 billion from the rush for its swine flu vaccine, after nine more governments gave the pharma giant orders for another 96 million doses2009-08-05T06:49:55ZGlaxo charges £6 for £1 swine flu vaccine
http://www.thisislondon.co.uk/standard/article-23722948-glaxo-charges-6-for-1-swine-flu-vaccine.do
Drug company producing most of Britain’s swine flu vaccine accused of profiteering from the pandemic as it hikes prices with 600% mark-up2009-07-22T13:06:28ZQ&A: Swine flu vaccine
http://www.thisislondon.co.uk/standard/article-23722927-qa-swine-flu-vaccine.do
Who is making the vaccine?2009-07-22T13:13:22ZGlaxoSmithKline’s double boost on cancer treatments
http://www.thisislondon.co.uk/standard-business/article-23717658-glaxosmithklines-double-boost-on-cancer-treatments.do
Pharma giant GlaxoSmithKline had a double injection of health, when the World Health Organisation approved its cervical cancer vaccine Cervarix and the British medical watchdog said it would reconsider its block on breast cancer treatment Tyverb’s use in the National Health Service2009-07-09T13:01:20ZGlaxo gets a boost from cervical cancer drug
http://www.thisislondon.co.uk/standard-business/article-23716323-glaxo-gets-a-boost-from-cervical-cancer-drug.do
British drug giant GlaxoSmithKline received a boost today after research into its cervical cancer vaccine Cervarix showed it is the only treatment to protect against five of the most common viruses associated with the disease2009-07-07T07:41:22ZGlaxo in £21 million China joint venture
http://www.thisislondon.co.uk/standard-business/article-23705210-glaxo-in-21-million-china-joint-venture.do
Britain's biggest pharmaceuticals giant GlaxoSmithKline today set up a joint venture with Shenzhen Neptunus to develop influenza vaccines for China2009-06-09T07:14:30ZGlaxo gets a fillip after WHO backs vaccine
http://www.thisislondon.co.uk/standard-business/article-23704317-glaxo-gets-a-fillip-after-who-backs-vaccine.do
Pharma giant GlaxoSmith Kline was today given a boost when the World Health Organisation endorsed its vaccine against a diarrhoea-causing virus that kills 500,000 children every year2009-06-05T12:15:10ZLong, profitable life of vaccines means it's not just the ill clamouring for them
http://www.thisislondon.co.uk/standard-business/article-23701881-long-profitable-life-of-vaccines-means-its-not-just-the-ill-clamouring-for-them.do
A dirty-brown brick building close to Northern Line station Mill Hill East is an unlikely place to find the saviour of the pharmaceuticals industry2009-06-01T07:35:24ZUS patent problems damage Glaxo health
http://www.thisislondon.co.uk/standard-business/article-23679349-us-patent-problems-damage-glaxo-health.do
The UK’s biggest pharmaceuticals firm, GlaxoSmithKline, blamed competition from American generic drugs as its first-quarter pre-tax profit fell 1.5% to £1.93 billion2009-04-22T13:15:05ZGlaxo pays £2.5bn for skin specialist
http://www.thisislondon.co.uk/standard-business/article-23678245-glaxo-pays-25bn-for-skin-specialist.do
The UK’s biggest pharmaceuticals firm GlaxoSmithKline has bought American skincare specialist Stiefel Laboratories for £2.5 billion2009-04-20T08:10:02ZGlaxo to co-promote Shire's Vyvanse drug
http://www.thisislondon.co.uk/standard-business/article-23669247-glaxo-to-co-promote-shires-vyvanse-drug.do
Shire has struck a deal with GlaxoSmithKline, the world's second largest drugs group, to co-promote its hyperactivity medicine Vyvanse in the United States, sending its shares sharply higher2009-03-31T11:01:47ZGlaxo revamps pay deal for new CEO Witty
http://www.thisislondon.co.uk/standard-business/article-23657724-glaxo-revamps-pay-deal-for-new-ceo-witty.do
GlaxoSmithKline has revamped the pay deal for its new chief executive Andrew Witty, who took over last May, following past controversies over remuneration at Europe's biggest drugmaker2009-03-04T16:25:58ZFlu drug orders go to Glaxo and Roche
http://www.thisislondon.co.uk/standard-business/article-23631372-flu-drug-orders-go-to-glaxo-and-roche.do
<strong> Health: </strong> The Government has ordered drugs by GlaxoSmithKline and Roche as it doubled its stockpile of anti-flu pandemic medicines2009-01-29T14:08:45ZGlaxo seals drugs deal and Pfizer eyes merger
http://www.thisislondon.co.uk/standard-business/article-23626525-glaxo-seals-drugs-deal-and-pfizer-eyes-merger.do
<strong>Health: </strong>There was a frenzy of activity in the pharmaceuticals sector with GlaxoSmithKline and Viagra maker Pfizer both involved in multi-million pound deals2009-01-23T09:05:56ZAnti-obesity pill is going on sale
http://www.thisislondon.co.uk/standard/article-23624745-anti-obesity-pill-is-going-on-sale.do
A pill that causes weight loss has been approved for sale in Britain without a prescription for the first time2009-01-21T14:42:44ZGlaxo eyes African medical firm Aspen
http://www.thisislondon.co.uk/standard-business/article-23621109-glaxo-eyes-african-medical-firm-aspen.do
<strong>Health: </strong> British pharmaceutical giant GlaxoSmithKline is believed to be eyeing up Africa’s largest pharmaceutical firm, Aspen Pharmacare, for a £940 million takeover2009-01-16T09:17:04ZWrongs and rights of a downturn
http://www.thisislondon.co.uk/standard-business/article-23612345-wrongs-and-rights-of-a-downturn.do
People tend to think that no one raises money on the stock market in an economic downturn and when share prices are low2009-01-06T10:24:53ZBitter pill as drugs giant AstraZeneca chops workers
http://www.thisislondon.co.uk/standard-business/article-23589983-bitter-pill-as-drugs-giant-astrazeneca-chops-workers.do
<strong>Pharmaceuticals:</strong> Drugs giant AstraZeneca is axeing 250 UK jobs as part of a plan to shed 1400 worldwide2008-11-20T10:30:30ZGlaxo S Africa deal opens way to emerging markets
http://www.thisislondon.co.uk/standard-business/article-23519677-glaxo-s-africa-deal-opens-way-to-emerging-markets.do
GlaxoSmithKline have taken a bold step into the branded generics market place through an alliance with South Africa's Aspen Pharmacare2008-07-23T14:07:17ZAnger over FDA 'brake on Glaxo'
http://www.thisislondon.co.uk/standard-business/article-23495860-anger-over-fda-brake-on-glaxo.do
US watchdog accused of posing new questions to Glaxo as it re-submits previously approved drugs2008-06-17T12:25:45ZAnger over FDA 'brake on Glaxo'
http://www.thisislondon.co.uk/standard-business/article-23495859-anger-over-fda-brake-on-glaxo.do
US watchdog accused of posing new questions to Glaxo as it re-submits previously approved drugs2008-06-17T12:25:37ZSticky issue of the RBS rights
http://www.thisislondon.co.uk/standard-business/article-23486163-sticky-issue-of-the-rbs-rights.do
Royal Bank of Scotland's share price sagged to 250p yesterday, and suddenly the 200p rights issue price it has set to raise £11 billion of new capital is not so far away2008-05-20T14:24:53ZAlistair Darling calls in City chiefs to avoid tax row exodus
http://www.thisislondon.co.uk/standard-business/article-23485752-alistair-darling-calls-in-city-chiefs-to-avoid-tax-row-exodus.do
The Chancellor is to bring senior executives from Britain's leading multinationals "into the tent" in a bid to stave off an exodus abroad of major companies over a tax row2008-05-19T15:05:53ZGlaxo lung drug gets a US boost
http://www.thisislondon.co.uk/standard-business/article-23481656-glaxo-lung-drug-gets-a-us-boost.do
US health regulators say GSK's Advair medicine is safe and effective for the wider treatment of patients with the lung disease COPD2008-05-01T15:23:13Z